Animal Intestinal Health Market Size and Share
Market Overview
| Study Period | 2020 - 2031 |
|---|---|
| Market Size (2026) | USD 5.68 Billion |
| Market Size (2031) | USD 8.38 Billion |
| Growth Rate (2026 - 2031) | 8.11% CAGR |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players *Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. | |
Animal Intestinal Health Market Analysis by Mordor Intelligence
The Animal Intestinal Health Market size is estimated at USD 5.68 billion in 2026, and is expected to reach USD 8.38 billion by 2031, at a CAGR of 8.11% during the forecast period (2026-2031).
Momentum follows the global shift away from antibiotic growth promoters toward evidence-based gut health solutions that safeguard productivity while conforming to regulatory limits. Demand also rises because intestinal disorders have become more prevalent in high-density production systems, thereby reducing feed efficiency and driving the adoption of preventive additives. Prebiotics, probiotics, immunostimulants, and phytogenics now form the core toolkit producers use to keep livestock performance on track. Artificial intelligence is broadening that toolkit by matching specific additive blends to each species’ and breed’s distinct microbiome, lowering trial-and-error costs and improving consistency. Meanwhile, supply chain complexity and premium raw material pricing place steady upward pressure on finished product costs, especially in price-sensitive regions.
Key Report Takeaways
- By livestock, swine held 29.45% of the animal intestinal health market share in 2025, while aquaculture is expanding at a 10.34% CAGR through 2031.
- By additive, prebiotics led with 27.54% revenue share in 2025; phytogenics post the fastest CAGR at 9.89% to 2031.
- By form, dry formats commanded 68.43% of the animal intestinal health market size in 2025, whereas liquid products are advancing at a 10.11% CAGR.
- By source, microbial ingredients accounted for 58.32% share in 2025, and plant-based sources are projected to grow at an 11.43% CAGR.
- By geography, North America dominated with 41.33% share in 2025, whereas Asia-Pacific is projected to register a 9.54% CAGR through 2031.
Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of January 2026.
Global Animal Intestinal Health Market Trends and Insights
Drivers Impact Analysis*
| Driver | (%) (~) Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Rising intestinal disorders among livestock | +2.1% | Global, most pronounced in intensive systems | Medium term (2-4 years) |
| Growth in functional animal-feed production | +1.8% | North America and EU, expanding to Asia-Pacific | Long term (≥ 4 years) |
| AGP bans shifting demand to gut-health aids | +2.3% | EU and North America, spillover to emerging markets | Short term (≤ 2 years) |
| Insect-protein farming spurring prebiotic use | +0.9% | Asia-Pacific core, adoption in Netherlands and Canada | Long term (≥ 4 years) |
| AI-driven microbiome profiling | +1.0% | United States, EU, Japan | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Rising Intestinal Disorders Among Livestock Drive Market Expansion
Higher stocking densities, faster growth cycles, and fluctuating temperatures have increased the prevalence of gut disorders in most commercial species. Post-weaning diarrhea now affects up to one-fifth of modern swine cohorts and has become costlier than respiratory disease in some units. Poultry producers navigating AGP withdrawals face similar pressure from necrotic enteritis outbreaks that trim weight gain and raise mortality. Producers calculate that each percentage point loss in feed conversion adds thousands of dollars to feed bills every cycle, prompting rapid investment in protective additives. Integrating probiotics and prebiotics into starter diets has cut diarrhea incidence by 30% in large trials. Demand therefore scales directly with the push to preserve margins without antibiotics, reinforcing the upward trajectory of the animal intestinal health market.
Functional Animal-Feed Production Growth Accelerates Additive Integration
Feed mills increasingly design complete rations that embed gut health ingredients instead of selling them as stand-alone supplements. The practice simplifies logistics for livestock enterprises and guarantees uniform additive delivery from the first to the last bite. Major European integrators have expanded functional-feed lines by nearly one-third since 2024. In parallel, extruders and pelleting lines have been upgraded with temperature-controlled zones that protect probiotic viability, allowing higher inclusion levels without sacrificing live-cell counts. Savings accrue because one production pass now accomplishes what used to require multiple on-farm steps, and additive makers benefit from more predictable off-take agreements with feed formulators. These trends anchor a structural rise in bulk orders and underpin sustained revenue growth for the animal intestinal health market.
AGP Bans Accelerate Transition to Gut Health Alternatives
Regulators have outlawed or curtailed antibiotic growth promoters across most of the developed world, and emerging economies are following suit. India’s food-safety agency extended its ban to additional drug classes in 2024, while Thailand introduced voluntary reduction targets that poultry exporters already meet to protect market access. Producers that relied on cheap AGPs now face a 12- to 18-month adjustment period in which performance dips unless replaced by robust gut-health programs. Combination packs featuring synergistic blends of probiotics, prebiotics, and phytogenics restore 95-98% of historical growth rates in European swine and poultry barns[1]European Food Safety Authority, “Scientific Opinion on the Safety of Phytogenics,” efsa.europa.eu. These documented field results strengthen confidence in non-antibiotic solutions and fast-track procurement decisions, enlarging the addressable base for the animal intestinal health market.
AI-Driven Microbiome Profiling Enables Precision Nutrition Strategies
Machine-learning platforms are lowering the cost of selecting the right additive for each flock, pond, or pen. Cargill, DSM, and several start-ups now offer services that analyze fecal or water microbiome samples, match observed microbial signatures to a proprietary strain database, and recommend an optimized formulation within a day[2]D. Kelly et al., “Machine Learning in Microbiome Analysis,” nature.com. Early adopters cite additive cost savings of 15-20% and steadier production metrics. The approach holds particular value in aquaculture, where variations in salinity, temperature, and stocking density destabilize microbial communities. Real-time dashboards signal when microbiome composition drifts outside target ranges, letting managers adjust dosing before disease pressure intensifies. Widespread rollout of these digital services promises to lock customer loyalty and expand high-margin revenue streams across the animal intestinal health market.
Restraints Impact Analysis*
| Restraint | (%) (~) Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Stringent regulatory approval timelines | −1.2% | Global, most acute in EU and North America | Medium term (2-4 years) |
| High cost of specialty gut-health ingredients | −0.8% | Latin America and parts of Asia | Short term (≤ 2 years) |
| Microbiome variability across breeds limits standardisation | −0.7% | Global, especially in multi-breed production systems | Long term (≥ 4 years) |
| Source: Mordor Intelligence | |||
Stringent Regulatory Approval Timelines Constrain Innovation Deployment
Bringing a novel probiotic or phytogenic to market can require two to three years of dossier preparation and review in major jurisdictions. EFSA’s Qualified Presumption of Safety process demands extensive genomic and toxicology data, while the U.S. FDA’s GRAS route insists on multi-species feeding trials that together can cost USD 2–5 million per application[3]European Food Safety Authority, “Regulatory Guidance for Feed Additives,” efsa.europa.eu. Such hurdles lengthen the payback period and deter small biotechnology firms from entering the space, narrowing the pipeline of disruptive solutions. Even large multinationals must stagger launches geographically to recoup cost, which slows the global diffusion of breakthroughs and tempers near-term expansion in the animal intestinal health market.
High Costs of Specialty Ingredients Limit Market Penetration
Advanced probiotic cultures and purified oligosaccharides command premiums three- to fivefold above conventional additives, pushing total feed costs up by as much as 12% in intensive systems. While vertically integrated producers in North America and Europe can absorb these costs, price-sensitive operators in Latin America and Southeast Asia often delay adoption or select cheaper, less potent alternatives. Manufacturers now experiment with lower-dose formulations and controlled-release coatings to stretch efficacy and mitigate price concerns. Success will hinge on proving that incremental performance gains outweigh extra feed expense, particularly where live-weight prices remain volatile.
*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.
Segment Analysis
By Livestock: Swine Remains Core While Aquaculture Surges
Swine contributed 29.45% to the animal intestinal health market size in 2025 as production systems tightened biosecurity and replaced AGPs with multi-strain probiotic and prebiotic packages. Post-weaning programs now emphasize early gut colonization to limit pathogenic E. coli proliferation that erodes growth. Meanwhile, aquaculture posts a 10.34% CAGR, the highest among all species, supported by rising seafood demand and chronic bacterial challenges in intensive ponds. Freshwater tilapia and brackish shrimp farms adopt coated probiotics that survive water dispersion and improve feed conversion. Poultry retains steady demand, mainly from broiler complexes combating necrotic enteritis after AGP removal. Ruminant adoption centers on calf and lamb starter feeds, with specialty blends easing the transition from milk to solid feed. Insect farming, led by black soldier fly larvae, appears small today but opens an innovative niche for targeted prebiotics that raise protein-conversion efficiency.
The animal intestinal health market share edge held by swine is expected to compress as aquaculture’s absolute spending climbs. Shrimp growers in Vietnam and India already dedicate up to 4% of feed budgets to gut additives, mirroring levels typical in swine systems. Competitive intensity therefore shifts toward water-stable formulations, with suppliers leveraging patents on micro-encapsulation and spore-forming strains. Cross-species platforms also gain traction, letting companies repurpose IP developed for terrestrial livestock in aquatic settings. This convergence lifts volumes and strengthens economies of scale across the value chain.
By Additive: Prebiotics Lead While Phytogenics Gain Ground
Prebiotics accounted for 27.54% of the animal intestinal health market share in 2025, anchored by fructo-oligosaccharides and mannan-rich fractions that enhance beneficial bacteria growth. Their compatibility with most regulatory frameworks and ability to tolerate high pelleting temperatures secure widespread usage. Phytogenics grow fastest at 9.89% CAGR, buoyed by plant-derived compounds such as essential oils that exhibit antimicrobial and anti-inflammatory properties without the residue concerns linked to synthetic additives. Probiotics comprise a mature but innovation-active cluster, with researchers tailoring strains for heat resistance and spore formation to widen use in pelleted feeds. Immunostimulants, while niche, attract attention for reducing vaccine-stress impacts in young animals.
Producers gravitate toward multi-component solutions that blend prebiotics with phytogenics, achieving synergistic action on microbial balance and intestinal integrity. This holistic tilt differentiates premium offerings and raises switching costs for end users. Suppliers that validate such combinations through peer-reviewed trials enjoy faster listing by international feed formulators. Regulatory bodies in the European Union and Brazil have begun approving specific phytogenic molecules, a milestone that encourages broader uptake and dilutes historical skepticism around botanical variability.
By Form: Dry Products Hold the Bulk, Liquids Scale Quickest
Dry formats generated 68.43% of the animal intestinal health market size in 2025 owing to easier handling, longer shelf life, and compatibility with existing feed-mill infrastructure. Uniform particle distribution in mash and pelleted rations ensures consistent intake without extra on-farm labor. Liquid additions, however, log a 10.11% CAGR, propelled by recirculating aquaculture systems and precision-feeding setups that meter supplements via automated pumps. Liquid carriers also allow higher inclusion of heat-sensitive compounds and enzymes that would denature during pelleting.
Manufacturers mitigate the packaging and cold-chain hurdles inherent to liquids by developing concentrated emulsions and shelf-stable paste formats. In swine nurseries, water-soluble probiotics deliver immediate gut support during stress periods such as transport and weaning. Dry-format leaders respond by upgrading micro-encapsulation technology to boost gastric acid resistance, leveling efficacy across forms. The resulting competition sharpens performance claims and expands choice for end users.
By Source: Microbial Dominance Meets Plant-Based Momentum
Microbial ingredients supplied 58.32% of 2025 revenue, benefiting from decades of fermentation know-how and scalable stainless-steel capacity worldwide. Robust quality systems maintain viable cell counts across long supply chains, reinforcing customer trust. Plant-based extracts now advance at an 11.43% CAGR, fueled by clean-label trends and breakthroughs in selective extraction that concentrate active phytochemicals. Algal beta-glucans and yeast-derived nucleotides occupy middle ground, bridging microbial and plant categories.
Sourcing diversification reduces reliance on corn and soybean streams tied to commodity price swings, a strategic plus during raw-material inflation. Additionally, synergistic blends combining microbial and plant actives reduce inclusion rates yet broaden functional coverage, appealing to integrators seeking fewer SKUs without performance trade-offs. Intellectual-property filings therefore increasingly target dual-source compositions that leverage distinct mechanisms for barrier function, immune modulation, and pathogen control.
Geography Analysis
North America held 41.33% of the animal intestinal health market in 2025, led by the United States, where mandatory veterinary feed directives and early AGP withdrawals fostered rapid alternative adoption. Large integrators deploy real-time monitoring devices that link pen-side sensors with cloud-based nutrition platforms, allowing quick dosing adjustments when gut dysbiosis signals emerge. Canada’s thriving black soldier fly sector also boosts prebiotic sales, as larvae growers refine microbiome management to improve protein yield, while Mexico’s feed industry scales probiotic use to satisfy export-market residue limits.
Asia-Pacific demonstrates the swiftest climb with a projected 9.54% CAGR, underpinned by surging fish and shrimp output and continued rise in regional protein demand. China’s post-ASF swine rebuilding accelerates spending on gut health to safeguard newly installed high-biosecurity units. India’s dairy cooperatives invest in calf nutrition programs to curb early-life scours and raise lifetime milk output. Japan and South Korea, characterized by high technology adoption, pilot AI-guided microbiome tools that refine additive selection, providing templates other nations aim to replicate.
Europe records solid, regulation-driven expansion as producers must comply with the world’s toughest antimicrobial curbs. Feed formulators there lead in functional-feed innovations, integrating multiple gut support agents into single pellets accepted by organic certification bodies. Scandinavian poultry complexes showcase low antibiotic-usage benchmarks through probiotics plus oat-based beta-glucans. In contrast, South America and the Middle East & Africa register lower current penetration but deliver new volume growth as local authorities tighten drug-residue controls and export-oriented farms seek certification.
Regulatory Landscape
Animal intestinal health solutions that are positioned as feed additives fall under different, tightly controlled frameworks across major markets. In the European Union, Regulation (EC) No 1831/2003 governs the authorization of feed additives, with EFSA conducting pre-market safety and efficacy assessments and approved products entering the EU Register of Feed Additives. The pace of EU authorizations continues to shape what can be marketed with performance claims: Commission Implementing Regulation (EU) 2026/356 (February 2026) authorized a zootechnical additive preparation of endo-1,4-beta-xylanase for gestating sows, and Commission Implementing Regulation (EU) 2026/1018 (May 2026) authorized a preparation containing Saccharomyces cerevisiae NBRC 0203 and Lacticaseibacillus rhamnosus NBRC 3425 for all animal species.
In the United States, the FDA Center for Veterinary Medicine regulates animal foods and feeds under the Federal Food, Drug, and Cosmetic Act, with specific compliance expectations for direct-fed microbial products set out in FDA policy. A recurring boundary for intestinal health products is the distinction between zootechnical or feed additive positioning versus drug claims when products are intended to affect the gastrointestinal tract; FDA communications encouraging early engagement on novel animal foods and drug-claim risks highlight this classification challenge. At the international level, WOAH standards and harmonization efforts such as VICH influence technical expectations and convergence discussions that affect dossier design, post-market oversight, and cross-border movement of gut-health-related animal nutrition products.
Value Chain Analysis
The value chain runs from upstream inputs (microbial strains, fermentation substrates, plant actives, carrier systems, and encapsulation or coating materials) to manufacturing (fermentation, drying, stabilization, blending, and protected-delivery processing). Downstream, products move through feed mills, integrators, premixers, veterinarians and nutrition advisers, and on-farm or aquaculture dosing systems. Scale advantages concentrate in fermentation capacity and quality systems that protect viability and consistency, which is particularly important for microbial ingredients that represented 58.32% of market revenue in 2025.
Recent actions show where capacity and processing know-how matter most. Cargill completed facility upgrades in Cedar Rapids, Iowa (March 2026) to expand postbiotic fermentation capacity within its Micronutrition & Health Solutions portfolio, reinforcing upstream supply for fermented bioactives. Midstream innovation also centers on protected delivery and stability through heat and storage, aligning with the market pattern that dry formats accounted for 68.43% of 2025 volume while liquids scale in precision dosing channels. Adisseo launched Sanion Tetra 50 and Sanion Tetra 70 (March 2026), high-concentration protected sodium butyrate additives for swine and poultry, and Trouw Nutrition introduced Presan Evolve (May 2026), combining botanical and target-release butyrate technologies for broilers. Downstream, product positioning and channel strategy differ by end use: livestock and aquaculture are commonly integrated into integrator and feed-mill programs, while companion animal gut health follows retail and direct-to-consumer pathways, including Jaguar Healths planned launch of a non-prescription, plant-based Neonorm Dog (May 2026).
Competitive Landscape
The animal intestinal health market remains moderately concentrated. DSM, Cargill, and Chr. Hansen together account for just under half of global revenue and leverage extensive fermentation assets, formulation labs, and regulatory teams to stay ahead. Their portfolios increasingly marry additive ranges with data analytics and advisory services, shifting the value proposition from commodity sales to outcome-based partnerships. Mid-tier incumbents, such as Kemin and Alltech, compete by focusing on niche actives like algae-derived immunomodulators or fermentation by-products that target specific production phases.
Strategic acquisitions shape the field. Cargill’s purchase of AquaHealth Solutions injects deep aquaculture know-how, while DSM-Firmenich’s USD 150 million digital-nutrition program funds cloud platforms that link microbiome sequencing with feed-mill automation. Start-ups bring genomic precision, using AI to predict strain efficacy before costly barn trials, and often license their libraries to larger players seeking a rapid way to refresh pipelines. Patent filings increasingly cover encapsulation designs that stabilize probiotics during feed processing, a vital differentiator as pelleting temperatures climb to inactivate pathogens.
Partnership patterns emphasize co-development with academic institutes to validate mechanisms, securing faster regulatory clearance and marketing traction. Suppliers also lock in exclusive distribution deals with regional feed mills, which guarantees baseline volumes and discourages brand switching. Competitive focus now shifts to insect and alternative-protein channels, where first movers aim to establish specifications that could become de facto standards as the segment scales.
Animal Intestinal Health Industry Leaders
AB Vista
DuPont
Kemin Industries, Inc.
Lesaffre
Bluestar Adisseo
- *Disclaimer: Major Players sorted in no particular order
Market Opportunities and Future Outlook
Regulatory clearances and scientific validation are creating whitespace for broader, species-spanning claims within authorized feed-additive pathways, particularly in the EU. Zootechnical additives can be marketed for performance-linked outcomes (for example, gut flora stabilization) but cannot be positioned as preventing or treating disease under Regulation (EC) No 1831/2003. The May 2026 EU authorization of a probiotic preparation containing Saccharomyces cerevisiae NBRC 0203 and Lacticaseibacillus rhamnosus NBRC 3425 for all animal species provides a concrete reference point for developers pursuing multi-species labels, and it raises the bar for dossier-backed efficacy across livestock categories.
Technology-led opportunity areas are centered more on higher precision and higher stability than on adding additional commodity strains. Peer-reviewed 2026 research points to next-generation approaches such as probiotic-vectored delivery of nanobodies targeting toxins relevant to sub-clinical necrotic enteritis in broilers, alongside multi-organism microbial bioactive complexes and newly identified Limosilactobacillus strains linked with feed-efficiency gains. At the same time, commercial investment is moving into production and formulation capabilities that can scale these concepts, including expanded fermentation capacity for postbiotics (Cargill, March 2026) and protected-release organic acid or butyrate platforms (Adisseo, March 2026; Trouw Nutrition, May 2026). Together, these signals point to opportunity in turnkey solutions that combine validated biology, protected delivery through pelleting and storage, and integrator-ready protocols that fit functional-feed manufacturing and increasingly data-driven nutrition programs.
Recent Industry Developments
- May 2026: Trouw Nutrition introduced Presan Evolve, a protected release butyrate technology combining botanical components for broilers, marking a step toward more targeted gut health solutions in commercial poultry programs. The launch aligns with integrated nutrition programs and could accelerate adoption by integrators and feed mills across global markets.
- July 2025: Lesaffre announced a strategic investment in CanBiocin to expand its companion animal care portfolio. The move strengthens its microbiome-oriented capabilities and extends distribution into consumer and veterinary-adjacent channels, supporting faster productization of gut health ingredients. The investment highlights a push to capture pet market opportunities alongside its livestock microbiology assets.
- May 2025: Kemin Industries acquired Bactana to accelerate fermentation and microbiome research. The deal enhances Kemin's in-house capabilities for intestinal health ingredients and supports broader reach across livestock and aquaculture segments. The acquisition aligns with a strategy to scale up advanced postbiotic and probiotic platforms in multi-species nutrition programs.
Research Methodology Framework and Report Scope
Market Definition and Coverage
For this report, the animal intestinal health market is defined as the value of feed additives and related nutrition inputs used to support gut function and intestinal balance in animals, which in turn supports digestion, immune defense, and overall performance outcomes.
Scope exclusions: We exclude therapeutic veterinary drugs and clinic-led treatments that are not sold or positioned as gut-health feed additives.
Segmentation Overview
- By Livestock
- Aquaculture
- Poultry
- Ruminant
- Swine
- Others
- By Additive
- Probiotics
- Prebiotics
- Immunostimulants
- Phytogenics
- By Form
- Dry
- Liquid
- By Source
- Microbial
- Plant-Based
- Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
- South America
- Brazil
- Argentina
- Rest of South America
- North America
Data Sources, Market Sizing, and Validation
Desk Research
Desk work was used to set the market boundaries and build the initial demand and supply map before assumptions were taken into interviews. We relied on public statistics and technical references such as FAOSTAT for livestock and aquaculture volumes, USDA and Eurostat for agriculture and feed indicators, and feed additive guidance from bodies such as the European Food Safety Authority and Codex Alimentarius.
To translate animal populations into a practical demand pool, we also reviewed trade and production signals where available, such as UN Comtrade for imports and exports of key additive categories, and scientific papers that clarify typical inclusion rates and functional claims for additives like probiotics and prebiotics. Company annual reports, investor presentations, and reputable industry press were used to cross-check business mix statements and geographic exposure, and we also used a paid subscription for company financials and patent landscaping where it helped clarify product focus. These sources are not exhaustive, and many other public documents and references were used for data collection, validation, and clarification.
Primary Interviews and Surveys
Primary discussions were used to validate what is actually purchased and used across livestock, aquaculture, and companion animal linked channels, and to confirm practical pricing, formulation shifts, and adoption barriers. We spoke with a mix of additive suppliers, premix and feed players, distributors, and end users, then rechecked key assumptions across APAC, EMEA, and the Americas so regional feeding practices and regulatory conditions were properly reflected.
Distribution of primary research fieldwork respondents
| Company type | Respondent position | Region |
|---|---|---|
| Top tier: 39% | CXOs: 14% | APAC: 52% |
| Mid tier: 44% | Functional/Unit leaders: 32% | EMEA: 30% |
| Smaller Players: 17% | Managers: 54% | Americas: 18% |
Market-Sizing & Forecasting
Sizing starts from a top-down demand pool build, where livestock and aquaculture output and animal headcount are converted into addressable feed volumes and then into additive consumption using adoption and inclusion-rate assumptions that are refined by interviews. The totals are subsequently stress-tested using selective bottom-up checks, such as sampled price per kilogram by additive type, channel margins, and a light roll-up of visible revenue exposure for suppliers where disclosures allow it.
Inputs that matter in this market include animal population by species, compound feed production trends, antibiotic reduction policies that shift diets toward functional additives, typical inclusion rates by form (dry versus liquid), and price movement tied to microbial and plant-based input availability. Because pricing can move faster than volumes in additives, we model ASP progression with a mix of observed spot signals from trade flows and expert-confirmed contracting behavior, and gaps are handled by using regional proxies where a country-level data series is thin.
For forecasting, scenario analysis is used, built around adoption speed, regulatory tightening, and livestock cycle conditions, then aligned to expert views on how quickly specific additive groups are substituted or combined in rations. The final forecast is kept repeatable by keeping every assumption linked to a measurable driver, and by limiting overrides to cases that can be explained on a call.
Data Validation & Update Cycle
Validation is done through several checks that look for mismatches between model outputs and independent signals, such as feed production direction, animal output trends, and trade movement of related additive inputs. When a country or segment shows an unusual jump, we revisit the assumption stack, check the math trail, and re-contact sources if the variance cannot be explained by a known event.
Before sign-off, the model is reviewed in steps by analysts not involved in the first build so that scope alignment, unit consistency, and currency treatment are checked again. Reports are refreshed annually, and interim updates are made when material events affect pricing, regulation, or animal production. Before delivery, we run a final freshness pass so clients receive the most current view that can be defended with clear drivers.
Mordor Intelligence's Animal Intestinal Health Market Size Compared Against Other Published Estimates
Published market sizes for animal intestinal health often spread out because the scope line is drawn differently and because pricing is treated differently across years. In practice, the biggest swings usually come from whether adjacent nutrition categories are counted, how quickly ASPs are assumed to rise, and what exchange-rate timing is used when local pricing is converted to USD.
A refresh-led build helps reduce these swings because assumptions get rechecked when new feed output, animal production, or additive trade signals shift direction, and because price logic is updated in the same currency window as the estimate year before it is consolidated. Those are the guardrails applied in Mordor Intelligence for the 2026 market value, which is why the number can look higher or lower than sources that keep older FX averages or apply a flat global ASP.
Benchmark comparison
| Source | Market Size | Gaps in Research Methodology |
|---|---|---|
| Mordor Intelligence | USD 5.68 B (2026) | |
| Trade Journal A | USD 4.01 B (2023) | Uses an earlier base year and may blend broader gut-health solutions with fewer validated adoption and inclusion-rate checks, which can understate the impact of recent additive pricing and uptake shifts. |
| Industry Newsletter B | USD 5.40 B (2027) | Forward value appears to apply a simplified growth path from a historical anchor and may not separate additive forms and sources consistently, which can skew ASP progression and the implied demand pool. |
Overall, the differences mainly come from timing and what gets counted as an intestinal-health additive versus a broader performance or health input. By keeping the demand pool tied to animal output and feed indicators, and then rechecking pricing and adoption through interviews, we arrive at a market value that is easier to trace and repeat year over year.
Key Questions Answered in the Report
What is the current value of the animal intestinal health market?
The sector is valued at USD 5.68 billion in 2026 and is projected to climb to USD 8.38 billion by 2031.
Which livestock category spends the most on gut health solutions?
Swine operations lead, representing 29.45% of global revenue in 2025.
Which additive type is growing the fastest?
Phytogenic compounds are expanding at a 9.89% CAGR through 2031.
Why is Asia-Pacific the fastest-growing region?
Rapid expansion of aquaculture and rising consumer demand for protein push the regional CAGR to 9.54%.
How are AI tools changing gut health management?
Machine-learning platforms match additive blends to specific microbiome profiles, cutting additive costs by up to 20% while improving consistency.
What level of market concentration exists among suppliers?
The market scores 6 on a 1–10 scale, indicating moderate concentration with room for disruptive entrants.
Page last updated on:
